Literature DB >> 101275

In-vitro activity of antimicrobial agents against Neisseria gonorrhoeae in Brussels.

R Vanhoof, M P Vanderlinden, J M Hubrechts, J P Butzler, E Yourassowsky.   

Abstract

The minimum inhibitory concentrations (MICs) of 18 antimicrobial agents against 104 strains of Neisseria gonorrhoeae isolated in the Brussels area between January and October 1976 have been measured. The MICs for penicillin G, ampicillin, amoxycillin, carbenicillin, and cephalexin showed a bimodal distribution. The second modus strains of cephalexin (MIC = 6.25 microgram/ml) were relatively resistant to penicillin G (MIC greater than or equal to 0.08 microgram/ml). About 51% of all strains were relatively resistant to penicillin G, 40.5% to ampicillin (MIC greater than or equal to 0.16 microgram/ml), 46% to amoxycillin, and 47.5% to carbenicillin. For cephalexin and cephaloridine, 25% and 8.5% respectively of all strains were relatively resistant (MIC greater than 3.12 microgram/ml). For cefazolin all MICs fell into a range of 0.097--3.12 microgram/ml. Resistance to tetracycline, doxycycline, minocycline, erythromycin, and spiramycin (MIC greater than or equal to 1 microgram/ml) was found in 9.5%, 7%, 6%, 36.5%, and 71% respectively of all isolates. No strains were resistant to rifampicin. For chloramphenicol and thiamphenicol the MICs ranged from 0.39 to 12.5 microgram/ml and from 0.195 to 3.12 microgram/ml respectively. The results for sulphamethoxazole, trimethoprim, and the combination of sulphamethoxazole and trimethoprim in a 20:1 ratio are given and discussed. The fractional inhibitory concentration (FIC) indices have also been calculated. No beta-lactamase-producing strains were found, and a contingency coefficient C has been determined for all the pairs of antibiotics investigated.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 101275      PMCID: PMC1045529          DOI: 10.1136/sti.54.5.309

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  18 in total

1.  Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae.

Authors:  M J Maness; P F Sparling
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

2.  Sensitivity to penicillin of Neisseria gonorrhoeae. Relationship to the results of treatment.

Authors:  D A Leigh; J Le Franc; A R Turnbull
Journal:  Br J Vener Dis       Date:  1969-06

3.  Antibiotic sensitivity of gonococcal strains isolated in the South-East Asia and Western Pacific regions in 1961-68.

Authors:  A Reyn
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  The problem of penicillin resistant gonococci.

Authors:  C S Nicol; M Ridley; M A Symonds
Journal:  Br J Vener Dis       Date:  1968-12

5.  Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam.

Authors:  E Stolz; H G Zwart; M F Michel
Journal:  Br J Vener Dis       Date:  1974-06

6.  Activity of eight antimicrobial agents in vitro against N. Gonorrhoeae.

Authors:  E Stolz; H G Zwart; M F Michel
Journal:  Br J Vener Dis       Date:  1975-08

7.  Susceptibility of Neisseria gonorrhoeae to seven antibiotics in vitro.

Authors:  H G Robson; I E Salit
Journal:  Can Med Assoc J       Date:  1972-11-18       Impact factor: 8.262

8.  Antibiotic sensitivities of Neisseria gonorrhoeae in the Toronto area.

Authors:  K F Givan; A Keyl
Journal:  Can Med Assoc J       Date:  1974-07-06       Impact factor: 8.262

9.  Comparative therapeutic and pharmacological evaluation of amoxicillin and ampicillin plus probenecid for the treatment of gonorrhea.

Authors:  W W Karney; M Turck; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

10.  Activity in vitro of ten antimicrobial agents against Neisseria gonorrhoeae. A study of the correlation between the sensitivities.

Authors:  A Meheus; P Piot; S Pattyn; E van Dyck; D van den Berghe
Journal:  Br J Vener Dis       Date:  1976-10
View more
  1 in total

1.  Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum.

Authors:  Graham Devereux; Douglas Fraser-Pitt; Jennifer Robertson; Edward Devlin; Derry Mercer; Deborah O'Neil
Journal:  EBioMedicine       Date:  2015-08-10       Impact factor: 8.143

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.